Did You Know...
...that after Parker Brothers executives turned down the game of Monopoly because it had "52 fundamental errors" (including taking too long to play), a copy of the game wound up in the home of the company president who stayed up until 1 a.m. to finish playing it? He was so impressed by the game that the next day he wrote to inventor Charles Darrow and offered to buy it!
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7563924 | 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments The present invention relates to 9-chloroprostaglandin derivatives of the general formula I which may be advantageous for the treatment of fertility problems. ... | 07/21/2009 |
| RE40703 | Cell differentiation inducer, benzamide compounds The novel benzamide derivative represented by formula (1) and the novel anilide derivative represented by formula (13) of this invention has differentiation-inducing effect, and are, therefore, useful a therapeutic or improving agent for malignant tumors, autoimmune... | 04/28/2009 |
| 7504410 | Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents This invention relates to pyrimidine derivatives of general formula (I) as inhibitors of kinases, their production as well as their use as medications for treating various diseases. ... | 03/17/2009 |
| 7473415 | Near infrared fluorescent contrast agent and method for fluorescence imaging A near infrared fluorescent contrast agent which is excellent in permeability in a living tissue and enables specific imaging of tumor and/or blood vessel, comprising a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, wherein R... | 01/06/2009 |
| 7429592 | Cyanoanthranilamide derivatives and the use thereof as medicaments Substituted cyanoanthranilamide derivatives, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described. The compounds according to the invention can be used as or in the case of psoriasis, Kap... | 09/30/2008 |
| 7378404 | 8β-hydrocarbyl-substituted estratrienes for use as selective estrogens This invention describes the new 8β-substituted estratrienes of general formula I in which R2, R3, R6, R6′, R7, R7′, R9, R11, R11′, R12, R14 | 05/27/2008 |
| 7345075 | 1,2 diarylbenzimidazoles and their pharmaceutical use Benzimidazoles of general formula I and the use of benzimidazole derivatives for the production of pharmaceutical agents for treatment and prophylaxis of diseases that are associated with a microglia activation are describe... | 03/18/2008 |
| 7335650 | Composition There is provided a pharmaceutical composition comprising (i) a compound of the formula wherein: X is a hydrocarbyl ring having at least 4 atoms in the ring; K is a hydrocarbyl group; Rs is a sulphamate group; (ii) optional... | 02/26/2008 |
| 7335775 | Effector conjugates, process for their production and their pharmaceutical use Conjugates of epothilones and epothilone derivatives (as effectors) with suitable biomolecules (as recognition units) are described. Their production is carried out by the effectors being reacted with suitable linkers, and the compounds that are produced are conjuga... | 02/26/2008 |
| 7329679 | 1,2 Diarylbenzimidazoles and their pharmaceutical use Benzimidazoles of general formula I and the use of benzimidazole derivatives for the production of pharmaceutical agents for treatment and prophylaxis of diseases that are associated with a microglia activation a... | 02/12/2008 |
| 7321044 | Synthesis of oxygen-substituted benzocycloheptenes as valuable intermediate products for the production of tissue-selective estrogens The invention relates to intermediate products and a new process for the production of benzocycloheptene C. The process for the production of its new intermediate products according to the invention starts from eco... | 01/22/2008 |
| 7317028 | Cell differentiation inducer The novel benzamide derivative represented by formula (1) and the novel anilide derivative represented by formula (13) of this invention has differentiation-inducing effect, and are, therefore, useful a therapeutic or improving agent for malignant tumors, autoimmune... | 01/08/2008 |
| 7297702 | Contraception method using competitive progesterone antagonists and novel compounds useful therein Competitive progesterone antagonists, including two novel steroids, viz., 11β,19-[4-(cyanophenyl)-o-phenylene]-17β-hydroxy-17α-(3-hydroxyprop-1(Z)-enyl)-4-androsten-3-one and 11β,19-[4-(3-pyridinyl)-o-phenylene]-17β-hydroxy-17α-(3-hydroxyprop-1(Z)-enyl)-4-andr... | 11/20/2007 |
| RE39678 | Meiosis regulating compounds Certain novel sterol derivatives can be used for regulating the meiosis in oocytes and in male germ cells. ... | 06/05/2007 |
| 7223798 | Lipoxin Aanalogs This invention is directed to lipoxin A4 analogs of the following formula (II): wherein R1, R2, R3, R4 and R5 are described herein. These analogs are ... | 05/29/2007 |
| 7220856 | Substituted quinoline CCR5 receptor antagonists The present invention relates to CCR5 receptor antagonists of formulae (1a) or (1b): enantiomers, diastereomers, salts and solvates thereof wherein R1, R2, R3, R | 05/22/2007 |
| 7211680 | Vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments Compounds of Formula I, wherein Y1, Y2, R1–R6, Q and Z are as defined herein, are vitamin D derivatives. These compounds are useful for, e.g., the treatment hyperprol... | 05/01/2007 |
| 7211241 | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes Described are new cascade polymer complexes, compositions containing them and use of the complexes in diagnosis and therapy, particularly for magnetic resonance imaging and computer tomography imaging. ... | 05/01/2007 |
| 7208140 | Trimeric macrocyclic substituted benzene derivatives The metal complexes of general formula I in which Hal stands for bromine or iodine and A1 and A2 have different meanings, are suitable as contrast media. ... | 04/24/2007 |
| 7202263 | N-heterocyclic derivatives as NOS inhibitors N-Heterocyclic derivatives of the following formula: where m, n, p, A1, R1, R2, R3 and R4 are described herein, as well as other N-heterocyclic derivatives, ... | 04/10/2007 |
| 7199268 | Process for the production of dendritic trimesic acid triamides A new process for the production of dendritic trimesic acid triamides is described. ... | 04/03/2007 |
| 7199146 | Imidazolidinedione analogs useful as anticoagulants and antithrombotics A compound is disclosed, which is useful in treating a mammal having a disease-state characterized by thrombotic activity. The compound is of the following formula: wherein A, B, R1, R2, R | 04/03/2007 |
| 7176013 | Modified corin molecules having substitute activation sequences and uses thereof This invention relates to novel modified corin molecules, or fragments or derivatives thereof, comprising a substitute activation sequence. The modified corin molecules are cleaved at the substitute activation sequence, thereby generating activated corin molecules, ... | 02/13/2007 |
| 7176207 | Platelet adenosine diphosphate receptor antagonists Compounds of the following formula (I): where A, a, b, R1, R2, R3, R4 and R6 are described herein, are useful as inhibitors of platelet adenosine diphosphate... | 02/13/2007 |
| 7166592 | Nonsteroidal antiinflammatory agents Compounds of Formula 1 are useful in the treatment of inflammation. ... | 01/23/2007 |
| 7163931 | Compositions of estrogen-cyclodextrin complexes Pharmaceutical compositions comprising low doses of sensitive complexes between an estrogen and a cyclodextrin are provided with improved stability. In specific embodiments the composition comprises a complex between ethinyl estradiol and β-cyclodextrin in a granul... | 01/16/2007 |
| 7148207 | Oral fludara of high-purity formulation with quick release of active ingredient This invention relates to a quick-release tablet formulation with >99.19% pure fludara (high-purity fludara) as an active ingredient in a defined composition of residual contaminants. ... | 12/12/2006 |
| 7141566 | Benzoxazine and benzothiazine derivatives and the use thereof in medicaments The invention relates to compounds of formula (I), the tautomeric and isomeric forms and salts thereof, in addition to a method for production and use thereof in medicaments. ... | 11/28/2006 |
| 7138379 | Use of the interferon receptor 2c polypeptide chain to enhance the anti-growth effects of type I interferons The present invention is directed towards a method of potentiating the anti-growth effects of type I interferon (IFN) on cells in a target cell population comprising increasing the number of functional IFNAR2c receptors on the surface of modified cells within the ta... | 11/21/2006 |
| 7129254 | Effector conjugates, process for their production and their pharmaceutical use Conjugates of epothilones and epothilone derivatives (as effectors) with suitable biomolecules (as recognition units) are described. Their production is carried out by the effectors being reacted with suitable linkers, and the compounds that are produced are conjuga... | 10/31/2006 |
| 7119082 | 11β-long-chain-substituted 19-nor-17α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ring This invention relates to new 19-nor-17α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ring with a long-chain substituent in 11β-position of general formula II in which R11 means a straight-... | 10/10/2006 |
| 7115645 | 1,2 diarylbenzimidazoles and their pharmaceutical use Benzimidazoles of general formula I and the use of benzimidazole derivatives for the production of pharmaceutical agents for treatment and prophylaxis of diseases that are associated with a microglia activation a... | 10/03/2006 |
| 7105563 | Indolinone derivatives and their use in treating disease-states such as cancer Indolinone derivatives, such as compounds of the formula (I): wherein A, m, n, R1, R2, R3, R5 and R6 are described herein, are discl... | 09/12/2006 |
| 7101880 | Peptidic compounds as cysteine protease inhibitors The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compo... | 09/05/2006 |
| 7084142 | Platelet adenosine diphosphate receptor antagonists Compounds of the following formula: where m, n, R1, R2, R3, R4 and R6 are described herein, are useful as inhibitors of platelet adenosine diphosphate. Pharm... | 08/01/2006 |
| 7067667 | Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors 3,4-dihydroquinoline derivatives, a process for their production and their use in pharmaceutical agents. ... | 06/27/2006 |
| 7056923 | Platelet adenosine diphosphate receptor antagonists Compounds of the following formula: where m, n, R1, R2, R3, R4 and R6 are described herein, are useful as inhibitors of platelet adenosine diphosphate. Pharm... | 06/06/2006 |
| 7053112 | Imidazolidinedione analogs useful as anticoagulants and antithrombotics A compound is disclosed, which is useful in treating a mammal having a disease-state characterized by thrombotic activity. The compound is of the following formula: wherein A, B, R1 | 05/30/2006 |
| 7033841 | Process and compounds for use in detecting analytes by measurement of residual magnetism, and the use of the said compounds The invention relates to a process for quantitative detection of analytes in liquid and solid phases with the aid of binding remanence measurement, compounds that are suitable for this purpose, and their use in analytic chemistry. ... | 04/25/2006 |
| 7026323 | Platelet adenosine diphosphate receptor antagonists Compounds of the following formula (I): where a, b, R1, R2, R3, R4 and R6 are described herein, are useful as inhibitors of platelet adenosine diphosphate. Pharmace... | 04/11/2006 |
